The latest clinical trial results from Eli Lilly show the drug manufacturer's once-weekly insulin injection is just as ...

A new study highlights promising results for a once-weekly insulin injection in managing blood sugar levels for people with ...

Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical ...

An investigational once-weekly insulin was noninferior to a daily option for patients with type 2 diabetes, but proved risky ...

Type 2 diabetes is characterized by the body's inability to use insulin effectively. Insulin is a hormone that helps regulate metabolism properly. The condition is the most common type of ...

Insulin efsitora alfa (efsitora) is a new basal insulin designed for once-weekly administration. Data on safety and efficacy have been limited to small, phase 1 or phase 2 trials. We conducted a ...

Alexandria, Louisiana A: Type 2 diabetes is almost always related to being overweight ... A second study out of Florida State ...

The late-stage clinical trial results showed that Eli Lilly’s once-weekly insulin efsitora matched daily injections for ...

Latent autoimmune diabetes (LADA) is sometimes referred to as type 1.5 diabetes. LADA usually develops in adults and ...

New research offers an alternative to daily insulin shots for the 8 million people in the United States with type 2 diabetes. Eli Lilly’s once-weekly insulin injection is just as effective as ...